Browsing publications by Professor Jaap Van Laar

Newcastle AuthorsTitleYearFull text
Professor Jaap Van Laar
Immunochip Analysis Identifies Multiple Susceptibility Loci for Systemic Sclerosis2014
Dr Marzena Ciechomska
Dr Steven O'Reilly
Monika Suwara
Professor Jaap Van Laar
MiR-29a Reduces TIMP-1 Production by Dermal Fibroblasts via Targeting TGF- β Activated Kinase 1 Binding Protein 1, Implications for Systemic Sclerosis2014
Professor Jaap Van Laar
Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteria2014
Dr Steven O'Reilly
Rachel Cant
Dr Marzena Ciechomska
James Finnigan
Professor Fiona Oakley
et al.
Serum amyloid A induces interleukin-6 in dermal fibroblasts via Toll-like receptor 2, interleukin-1 receptor-associated kinase 4 and nuclear factor-kappa B2014
Gill Wheater
Dr Mohsen Elshahaly
Dr Stephen Tuck
Dr John Drury
Professor Jaap Van Laar
et al.
Bone marker reference range study: a comparison of the manufacturer’s reference range and laboratory healthy volunteer results to patients with rheumatoid arthritis2013
Dr Mohsen Elshahaly
Gill Wheater
Dr Stephen Tuck
Dr Harish Datta
Professor Fai Ng
et al.
Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, a B cell depleting monoclonal antibody (HORUS TRIAL)2013
Professor Jaap Van Laar
Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study2013
Dr Steven O'Reilly
Rachel Cant
Dr Marzena Ciechomska
Professor Jaap Van Laar
Interleukin-6: a new therapeutic target in systemic sclerosis?2013
Dr Marzena Ciechomska
Rachel Cant
James Finnigan
Professor Jaap Van Laar
Dr Steven O'Reilly
et al.
Role of toll-like receptors in systemic sclerosis2013
Professor Jaap Van Laar
Strontium ranelate: ready for clinical use as disease-modifying osteoarthritis drug?2013
12345678910111213